Piper Jaffray Companies set a $77.00 price target on Encompass Health (AMEX:EHC) in a report released on Wednesday, TipRanks reports. The firm currently has a buy rating on the stock. Piper Jaffray Companies also issued estimates for Encompass Health’s Q4 2019 earnings at $0.86 EPS, FY2019 earnings at $3.88 EPS, Q1 2020 earnings at $0.93 EPS, Q2 2020 earnings at $0.92 EPS, Q3 2020 earnings at $0.90 EPS, Q4 2020 earnings at $0.88 EPS, FY2020 earnings at $3.63 EPS, Q1 2021 earnings at $0.99 EPS, Q2 2021 earnings at $0.98 EPS and FY2021 earnings at $3.93 EPS.
Several other analysts have also weighed in on the company. Raymond James lowered their price objective on Encompass Health from $80.00 to $75.00 and set an outperform rating for the company in a report on Wednesday. Barclays raised Encompass Health from an equal weight rating to an overweight rating and upped their target price for the company from $68.00 to $70.00 in a report on Thursday, May 30th. Zacks Investment Research lowered Encompass Health from a hold rating to a sell rating in a report on Tuesday. Finally, BMO Capital Markets began coverage on Encompass Health in a report on Thursday, June 27th. They set an outperform rating and a $72.00 target price for the company. One analyst has rated the stock with a sell rating and six have given a buy rating to the company. Encompass Health presently has a consensus rating of Buy and a consensus target price of $75.00.
Encompass Health has a one year low of $40.86 and a one year high of $59.29.
The firm also recently disclosed a quarterly dividend, which was paid on Monday, July 15th. Stockholders of record on Monday, July 1st were given a dividend of $0.27 per share. The ex-dividend date was Friday, June 28th. This represents a $1.08 annualized dividend and a dividend yield of ∞.
About Encompass Health
Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.
Further Reading: What is the downside to momentum investing?
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.